Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials
Johannes Holtschmidt, A. Schneeweiss, Nadine Frickel, Natalie Filmann et autres
Abstract Background: Residual invasive disease after NACT for TNBC is associated with high recurrence rates and poor overall survival (OS). The assessment of pathologic complete response (pCR) vs. non-pCR in early breast cancer is not consistently linked to OS. For instance, it …
de, ee, pl (code pays fourni par la source)
3 citations
Clinical Cancer Research